<DOC>
	<DOCNO>NCT01947491</DOCNO>
	<brief_summary>The objective study compare safety DFD01 Spray Comp01 Lotion topical treatment moderate plaque psoriasis compare efficacy DFD01 Spray Placebo Spray topical treatment moderate plaque psoriasis 28 day treatment .</brief_summary>
	<brief_title>A Comparison DFD01 Spray Versus Comp01 Lotion , Vehicle Spray Vehicle Lotion Subjects With Moderate Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects must present clinical diagnosis stable ( least 3 month ) plaquetype psoriasis . Subjects psoriasis involve 10 20 % BSA , include face , scalp , groin , axillae intertriginous area . Subjects must IGA grade 3 ( moderate ) Baseline Visit Current diagnosis unstable form psoriasis include guttate , erythrodermic , exfoliative pustular psoriasis . Other inflammatory skin disease may confound evaluation plaque psoriasis ( e.g. , atopic dermatitis , contact dermatitis , tinea corporis ) . Presence pigmentation , extensive scarring , pigment lesion sunburn could interfere rating efficacy parameter . History psoriasis unresponsive topical treatment . History organ transplant require immunosuppression , HIV , immunocompromised state .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>